SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,801 | +9.4% | 3,605 | -0.8% | 0.00% | – |
| Q2 2023 | $699,207 | -94.3% | 3,633 | -94.0% | 0.00% | -100.0% |
| Q1 2023 | $12,295,598 | +188.6% | 60,728 | +83.0% | 0.01% | +133.3% |
| Q4 2022 | $4,261,086 | +16.2% | 33,189 | +23.0% | 0.00% | 0.0% |
| Q3 2022 | $3,666,765 | -42.7% | 26,985 | -24.6% | 0.00% | -25.0% |
| Q2 2022 | $6,398,751 | -15.2% | 35,789 | -32.7% | 0.00% | -20.0% |
| Q1 2022 | $7,543,662 | +1385.0% | 53,210 | +1544.3% | 0.01% | – |
| Q4 2021 | $508,000 | -16.4% | 3,236 | -9.7% | 0.00% | – |
| Q3 2021 | $608,000 | +7.4% | 3,582 | 0.0% | 0.00% | – |
| Q2 2021 | $566,000 | +13.9% | 3,582 | 0.0% | 0.00% | – |
| Q1 2021 | $497,000 | -20.7% | 3,582 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $627,000 | – | 3,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |